Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 4/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.61 |
| ▸ | POLA1 | P09884 | 1/20 | 0.59 |
| ▸ | POLD1 | P28340 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triphosphate SCHEMBL7631515 | 1.00 | TYMS (0.62) | TYMSPOLBPOLA1POLD1 | |
| SCHEMBL1163795 | 1.00 | TYMS (0.62) | TYMSPOLBPOLA1POLD1 | |
| SCHEMBL13551342 | 1.00 | TYMS (0.62) | TYMSPOLBPOLA1POLD1 | |
| SCHEMBL15810821 | 1.00 | TYMS (0.62) | TYMSPOLBPOLA1POLD1 | |
| SCHEMBL3235048 | 0.90 | TYMS (0.74) | TYMS | |
| SCHEMBL17117806 | 0.90 | TYMS (0.74) | TYMS | |
| SCHEMBL335865 | 0.90 | TYMS (0.74) | TYMS | |
| SCHEMBL6462543 | 0.89 | POLB (0.62) | TYMSPOLBPOLA1POLD1 | |
| SCHEMBL149769 | 0.89 | POLB (0.62) | TYMSPOLBPOLA1POLD1 | |
| SCHEMBL12758590 | 0.89 | TYMS (0.63) | TYMSPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1264 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250263766-A1 | NUCLEIC ACID AND GENE SYNTHESIS | NunaBio Limited (GB) | 2025-08-21 | — | — | US | claimed |
| US-20250210148-A1 | METHOD OF PRODUCING DATA-ENCODED NUCLEIC ACID AND NUCLEIC ACID PRODUCED BY THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-06-26 | — | — | US | claimed |
| EP-4536855-A1 | NUCLEIC ACID AND GENE SYNTHESIS | NunaBio Limited (GB) | 2025-04-16 | — | — | EP | claimed |
| EP-4481057-A1 | SAMPLE PREPARATION METHODS USING MODIFIED BASES FOR RAPID IDENTIFICATION AND SEQUENCING | Depixus (FR) | 2024-12-25 | — | — | EP | claimed |
| US-20240309447-A1 | METHODS AND KITS FOR PREPARING A SAMPLE COMPRISING ONE OR MORE RNA MOLECULES FOR SEQUENCING | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2024-09-19 | — | — | US | claimed |
| WO-2023237889-A1 | NUCLEIC ACID AND GENE SYNTHESIS | NunaBio Limited (GB) | 2023-12-14 | — | — | WO | claimed |
| US-10799602-B2 | Method for increasing expression of RNA-encoded proteins | CUREVAC AG (DE) | 2020-10-13 | — | — | US | claimed |
| US-10293060-B2 | Method for increasing expression of RNA-encoded proteins | CUREVAC AG (DE) | 2019-05-21 | — | — | US | claimed |
| US-20190100784-A1 | RNA ANALYSIS BY TOTAL HYDROLYSIS | CureVac SE (DE) | 2019-04-04 | — | — | US | claimed |
| EP-3423595-A1 | RNA ANALYSIS BY TOTAL HYDROLYSIS | CureVac AG (DE) | 2019-01-09 | — | — | EP | claimed |
| US-7488577-B2 | non-radioactive assay in microtiter plate format enabling colorimetric or fluorimetric product detection for drug screening; solid phase synthesis | CAVIDI TECH AB (SE) | 2009-02-10 | — | — | US | claimed |
| EP-1395675-B1 | A METHOD FOR MEASURING DNA POLYMERIZATION AND APPLICATIONS OF THE METHOD | CAVIDI TECH AB (SE) | 2006-01-18 | — | — | EP | claimed |
| US-20040157230-A1 | Method for measuring dna polymerization and applications of the method | CAVIDI AB (SE) | 2004-08-12 | — | — | US | claimed |
| US-20030039976-A1 | Methods for base counting | PE CORPORATION (NY) | 2003-02-27 | — | — | US | claimed |
| US-5985266-A | SENSITIZE TUMORS, RETROVIRUS COMPRISES OPERATIVELY LINKED TO A PROMOTER A GENE ENCODING A VIRAL THYMIDINE KINASE; SUCH THAT SAID TUMOR CELLS BECOME TRANSDUCED BY SAID RETROVIRUS AND EXPRESS SAID VIRAL THYMIDINE KINASE GENE; | HUMAN GENE THERAPY RESEARCH INSTITUTE (US) | 1999-11-16 | — | — | US | claimed |
| EP-4747380-A1 | MODULATING EXPRESSION OF ALAS1 (5'-AMINOLEVULINATE SYNTHASE 1) GENE | CRISPR Therapeutics AG (CH) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026103936-A1 | CHEMICALLY MODIFIED CIRCULAR RNA MOLECULE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 上海元码智药生物技术有限公司 | 2026-05-21 | — | — | WO | disclosed |
| US-4749647-A | Polymerization-induced separation assay using recognition pairs | GENETIC SYSTEMS CORPORATION (US) | 1988-06-07 | — | — | US | disclosed |
| US-4699876-A | ZYMOGEN ACTIVATED ENZYMATIC REACTION CASCADE TO DETECT HYBRIDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-10-13 | — | — | US | disclosed |
| EP-0151001-A2 | Nonradiometric polynucleotide probes | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-08-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10293060-B2 | Method for increasing expression of RNA-encoded proteins | STING1, UPF1, CUTA | TYMS 2618/4885POLB 273/4885POLA1 291/4885 |
| US-10799602-B2 | Method for increasing expression of RNA-encoded proteins | STING1, UPF1, CUTA | TYMS 2618/4885POLB 273/4885POLA1 291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.